UTHR FY 2018 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.6B-5.7% YoY

Gross Profit

$1.4B87.8% margin

Operating Income

$805M49.5% margin

Net Income

$589M36.2% margin

EPS (Diluted)

$13.39

Cash Flow

Operating Cash Flow

$778M

Free Cash Flow

$594M

Stock-Based Comp.

-$26M

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$612M

Stockholders' Equity

$2.8B

Cash & Equivalents

$669M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.7B	-5.7%
Gross Profit	$1.4B	$1.6B	-11.8%
Operating Income	$805M	$815M	-1.2%
Net Income	$589M	$418M	+41.0%